OR WAIT null SECS
June 03, 2019
The US Pharmacopeial Convention released new and revised standards for compounding nonsterile medicines, sterile medicines, and radiopharmaceutical drugs.
June 02, 2019
CDER’s KASA program seeks manufacturer data on drug attributes and risks to inform oversight.
A good working relationship between sponsor and contractor will become invaluable when an OOS occurs, says Susan J. Schniepp, executive vice-president of post-approval pharma and distinguished fellow, Regulatory Compliance Associates.
Quality and compliance depend on the right approaches to training, standard operating procedures, and validation. More tools are available to help ensure success.
Protecting the integrity of raw data is crucial to regulatory compliance and to proving that manufacturing and quality operations are being run and managed properly.
May 30, 2019
The company is voluntarily recalling Amikacin Sulfate Injection, USP, 1g/4 mL (250mg/mL), and Prochlorperazine Edisylate Injection, USP, 10mg/2mL (5mg/mL), to the consumer level because microbial growth was detected.
May 22, 2019
Violations found by FDA included a failure to test product for API identity and strength, failure to validate outsourced materials, and a lack of written cleaning procedures.
Inspectors found a lack of control over computer systems and a failure to follow equipment cleaning and maintenance procedures.
May 17, 2019
TraceLink will participate in the agency’s Pilot Project Program under the Drug Supply Chain Security Act.
May 15, 2019
The company is recalling the lots because of possible peanut flour contamination.